Chiesi appoints Giuseppe Accogli as new Group CEO
/PRNewswire/ -- Chiesi, the international research-focused biopharmaceutical Group, is pleased to announce Giuseppe Accogli as new Group CEO. He will join...
Source: prnewswire.com
Marco Vecchia News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Marco Vecchia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Marco Vecchia Today - Breaking & Trending Today
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc ... | January 8, 2023
Source: marketscreener.com
Irish pharma company Amryt snapped up for up to $1.5bn
Italy’s Chiesi is acquiring Amryt Pharma, known for its breakthrough therapy targeting epidermolysis bullosa, also known as ‘butterfly skin’.
Source: siliconrepublic.com
Chiesi Farmaceutici Acquires Amryt Pharma, for Up To US$1.48 Billion
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Chiesi Ups Rare Disease Game with $1.48B Amryt Acquisition
Italian biopharma Chiesi Farmaceutici SpA announced Sunday it was acquiring rare disease-focused Amryt Pharma in a deal that could reach up to $1.48 billion in value.
Source: biospace.com